Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
59
CIMA_AEMPS:25
NMPA:15
EMA:11
+1 more agencies
Drug Approvals
Recombinant Human Choriogonadotropin alfa Solution for Injection
- Product Name
- 艾泽
- Approval Number
- 国药准字SJ20130091
- Approval Date
- Aug 2, 2023
NMPA
Recombinant Human Follitropin Alfa Solution for Injection
- Product Name
- 果纳芬
- Approval Number
- 国药准字SJ20235002
- Approval Date
- May 11, 2023
NMPA
Recombinant Human Follitropin for Injection
- Product Name
- 果纳芬
- Approval Number
- 国药准字SJ20181008
- Approval Date
- Jan 16, 2023
NMPA
Cetuximab Solution for Infusion
- Product Name
- 爱必妥
- Approval Number
- 国药准字SJ20171039
- Approval Date
- Oct 10, 2022
NMPA
Recombinant Human Lutropin alfa for Injection
- Product Name
- 乐芮
- Approval Number
- 国药准字SJ20181004
- Approval Date
- Oct 10, 2022
NMPA
Recombinant Human Lutropin alfa for Injection
- Product Name
- 乐芮
- Approval Number
- 国药准字SJ20181005
- Approval Date
- Oct 10, 2022
NMPA
Recombinant Human Follitropin Alfa Solution for Injection
- Product Name
- 果纳芬
- Approval Number
- 国药准字SJ20160041
- Approval Date
- Aug 27, 2021
NMPA
Recombinant Human Follitropin Alfa Solution for Injection
- Product Name
- 果纳芬
- Approval Number
- 国药准字SJ20160040
- Approval Date
- Aug 27, 2021
NMPA
Recombinant Human Follitropin Alfa Solution for Injection
- Product Name
- 果纳芬
- Approval Number
- 国药准字SJ20160039
- Approval Date
- Aug 27, 2021
NMPA
Recombinant Human Choriogonadotropin alfa Solution for Injection
- Product Name
- 艾泽
- Approval Number
- S20130091
- Approval Date
- Mar 26, 2020
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found